標(biāo)題: Titlebook: New Approaches in Cancer Pharmacology: Drug Design and Development; Paul Workman (Chairman and Editor) Conference proceedings 1992 Springe [打印本頁(yè)] 作者: Coagulant 時(shí)間: 2025-3-21 18:46
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development影響因子(影響力)
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development影響因子(影響力)學(xué)科排名
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development被引頻次
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development被引頻次學(xué)科排名
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development年度引用
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development年度引用學(xué)科排名
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development讀者反饋
書(shū)目名稱New Approaches in Cancer Pharmacology: Drug Design and Development讀者反饋學(xué)科排名
作者: 脾氣暴躁的人 時(shí)間: 2025-3-21 22:50 作者: 英寸 時(shí)間: 2025-3-22 00:38 作者: Ferritin 時(shí)間: 2025-3-22 06:35
Prospects for Biological and Gene Therapies,om the outset. Despite the encouraging success of chemotherapy for a variety of rare tumour types, in the vast majority of human solid cancers such treatment has had little impact on survival. This is disappointing considering the tremendous efforts of the last 20 years.作者: Nonconformist 時(shí)間: 2025-3-22 09:26
Conference proceedings 1992atment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly作者: 灌溉 時(shí)間: 2025-3-22 14:14
Antisense and Antigene Oligonucleotides Targeted to Oncogenes,tion of tumour-suppressor genes represent new strategies that should lead i) to a better understanding of the different steps involved in tumourigenesis, and ii) to the development of new therapeutic approaches.作者: llibretto 時(shí)間: 2025-3-22 19:39 作者: 冰雹 時(shí)間: 2025-3-22 21:36
978-3-642-77876-6Springer-Verlag Berlin Heidelberg 1992作者: Notorious 時(shí)間: 2025-3-23 04:56 作者: 抱負(fù) 時(shí)間: 2025-3-23 05:39
Current Strategies in Anticancer Drug Discovery Within the EORTC,Advances in the treatment of malignant diseases have been limited by our failure to identify unique biochemical and/or biological properties which are able to clearly distinguish cancer cells from the normal cell population. Consequently, currently available anticancer agents lack tumour selectivity and possess a narrow therapeutic index [1].作者: APO 時(shí)間: 2025-3-23 10:06
ESO Monographshttp://image.papertrans.cn/n/image/664788.jpg作者: paleolithic 時(shí)間: 2025-3-23 16:53
https://doi.org/10.1007/978-3-642-77874-2DNA; Gentherapie; Krebstherapie; Onkogene; cancer; cancer therapy; drug; drug design; gene therapy; oncogenes作者: 一夫一妻制 時(shí)間: 2025-3-23 19:02
New Approaches in Cancer Pharmacology: Drug Design and Development作者: 緊張過(guò)度 時(shí)間: 2025-3-23 22:58
New Approaches in Cancer Pharmacology: Drug Design and Development978-3-642-77874-2作者: 拖網(wǎng) 時(shí)間: 2025-3-24 05:31
nt optimization approaches to timing yield and contrast them to deterministic optimization. The work will enable new researchers in this area to come up to speed quickly, as well as provide a handy reference for those already working in CAD tool development..978-1-4419-3827-5978-0-387-26528-5Series ISSN 1558-9412 Series E-ISSN 1558-9420 作者: Malleable 時(shí)間: 2025-3-24 09:19 作者: fender 時(shí)間: 2025-3-24 11:56
Maurizio D’lncalci,Massimo Broggini,John A. Hartleyo longer separable. By tying the coordinates together, the hope is to gain adaptivity and achieve automatic hyperparameter tuning. Here, we study two examples of fully Bayes penalties: the fully Bayes LASSO and the fully Bayes Spike-and-Slab LASSO of Ro?ková and George (The Spike-and-Slab LASSO, Sub作者: 刺耳 時(shí)間: 2025-3-24 18:31 作者: 消耗 時(shí)間: 2025-3-24 19:07 作者: 深陷 時(shí)間: 2025-3-24 23:10
John A. Hickmanissues, and tissues subjected to laser capture microdissection (LCM), to identify the analyte with the lowest variability. Specific normalization analytes were found to be advantageous for different classes of samples, with ssDNA being the optimal analyte to normalize blood contaminated samples.作者: MUTE 時(shí)間: 2025-3-25 05:31
Michael Jarmanissues, and tissues subjected to laser capture microdissection (LCM), to identify the analyte with the lowest variability. Specific normalization analytes were found to be advantageous for different classes of samples, with ssDNA being the optimal analyte to normalize blood contaminated samples.作者: 平庸的人或物 時(shí)間: 2025-3-25 09:36
G. Schwartsmannaction, to build a discriminant rule that classifies samples in one of several disease stages, thus helping diagnosis. The restricted discriminant rules are compared with some standard classifiers that do not take into account the additional information, showing better performance in terms of error 作者: 偉大 時(shí)間: 2025-3-25 13:02
Paul Workmanlso for biologists, biochemists, and medical researchers who want to learn more about the statistical opportunities in the analysis of proteomics data..978-1-4939-7987-5978-1-4939-3106-4Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: Annotate 時(shí)間: 2025-3-25 18:19
Merrill J. Egorinlso for biologists, biochemists, and medical researchers who want to learn more about the statistical opportunities in the analysis of proteomics data..978-1-4939-7987-5978-1-4939-3106-4Series ISSN 1064-3745 Series E-ISSN 1940-6029 作者: tenosynovitis 時(shí)間: 2025-3-25 21:26 作者: 分解 時(shí)間: 2025-3-26 01:49 作者: declamation 時(shí)間: 2025-3-26 06:33 作者: 放大 時(shí)間: 2025-3-26 08:29 作者: 是突襲 時(shí)間: 2025-3-26 13:38
Sequence and Gene-Specific Drugs,o normal tissues, they possess some degree of selectivity and specificity against a variety of human tumours. There are tumours which are particularly sensitive to DNA-interacting agents (e.g. testicular tumours are often curable with cis-platin), but the reasons for this peculiar sensitivity are st作者: Trabeculoplasty 時(shí)間: 2025-3-26 19:22 作者: 序曲 時(shí)間: 2025-3-26 21:32
Prospects for Biological and Gene Therapies,cancer therapy aims to bring about the selective destruction of the tumour, leaving as much as possible of normal tissue intact. The fundamental stumbling block of surgery and radiotherapy is the problem of tumour invasion and spread outside areas directly accessible to these modalities of treatment作者: 杠桿 時(shí)間: 2025-3-27 04:29
Membrane and Signal Transduction Targets, present a formidable challenge to drug discovery teams. How can this knowledge be harnessed and the approach emulated? Sadly, the elegance and precision of some of the insights provided by molecular and cellular biologists have not yet been matched by the efforts of medicinal chemists and pharmacol作者: insert 時(shí)間: 2025-3-27 07:09 作者: 重力 時(shí)間: 2025-3-27 13:09 作者: 燦爛 時(shí)間: 2025-3-27 14:36 作者: STENT 時(shí)間: 2025-3-27 21:06 作者: TOXIC 時(shí)間: 2025-3-27 22:18
Paul Workmangorous mathematical treatment of this subject with over 500 .Statistical Analysis and Optimization For VLSI: Timing and Power is a state-of-the-art book on the newly emerging field of statistical computer-aided design (CAD) tools. The very latest research in statistical timing and power analysis tec作者: 沉著 時(shí)間: 2025-3-28 05:34 作者: 冷淡周邊 時(shí)間: 2025-3-28 06:36
Claude Hélèneion and prediction in genomics. Preselection—to start with a manageable set of covariates—is becoming increasingly necessary for enabling advanced analysis tasks to be carried out on data sets of huge size created by high throughput technologies. Preselection of features to be included in multivaria作者: 威脅你 時(shí)間: 2025-3-28 12:02
Karol Sikora,Andres Guiterrezposttranslational modified forms, in a small clinical sample. Data normalization is fundamental for this technology, to correct for the sample-to-sample variability in the many possible confounding factors: extracellular proteins, red blood cells, different number of cells in the sample. To address 作者: pus840 時(shí)間: 2025-3-28 18:17 作者: 鳥(niǎo)籠 時(shí)間: 2025-3-28 21:03 作者: Parameter 時(shí)間: 2025-3-29 02:09
Paul Workmane results.Contains key notes and implementation advice from .This valuable collection aims to provide a collection of frequently used statistical methods in the field of proteomics. Although there is a large overlap between statistical methods for the different ‘omics’ fields, methods for analyzing 作者: 內(nèi)行 時(shí)間: 2025-3-29 03:53
Merrill J. Egorine results.Contains key notes and implementation advice from .This valuable collection aims to provide a collection of frequently used statistical methods in the field of proteomics. Although there is a large overlap between statistical methods for the different ‘omics’ fields, methods for analyzing
